OneMedNet Corp · Valuation · TradingHolo

OneMedNet Corp · Valuation · TradingHolo

Multiples

Shown only where the company is comparable with its peers

Multiple	Now	Sector median	Where it sits
P/E	−10.5×	−1.8×
Price / Book	−10.0×	2.1×
Price / Sales	21.7×	4.0×
Price / Free cash flow	−3.9×	−1.6×
EV / EBITDA	−11.1×	−1.1×
Earnings yield	−9.5%	−14.1%
Free cash flow yield	−25.5%	−9.5%

P/E at each quarterly report

Price at the report date ÷ trailing twelve-month earnings

No comparable valuation history is available.

Peers

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
NYSE:LLYEli Lilly and Co · 🇺🇸 NYSE	$1,283.20	−1.80%	$1.21T	59.6×	77.8%	+21.1%
NYSE:JNJJohnson & Johnson · 🇺🇸 NYSE	$263.46	−1.55%	$634.23B	24.0×	32.9%	+39.5%
NYSE:ABBVAbbVie Inc · 🇺🇸 NYSE	$282.93	−0.79%	$499.97B	119.3×	−129.2%	+23.3%
NYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE	$421.33	−0.86%	$378.18B	31.6×	12.8%	+16.3%
NYSE:MRKMerck & Co Inc · 🇺🇸 NYSE	$144.14	−2.11%	$355.62B	19.9×	34.7%	+68.0%
NYSE:NVSNovartis AG · 🇺🇸 NYSE	$155.54	−0.47%	$280.28B	20.0×	30.5%	+19.0%
NYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE	$170.93	−0.95%	$265.1B	26.1×	21.1%	+3.3%
NYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE	$673.56	−0.44%	$249.05B	37.1×	12.6%	+21.2%
NAS:AMGNAmgen Inc · 🇺🇸 NAS	$440.80	−1.45%	$238.31B	31.4×	89.1%	+48.5%
NAS:GILDGilead Sciences Inc · 🇺🇸 NAS	$156.97	−0.14%	$194.63B	22.9×	37.5%	+26.7%